Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension
- 1 November 1988
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (16) , 1072-1077
- https://doi.org/10.1016/0002-9149(88)90551-6
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Efficacy and tolerance of spironolactone in essential hypertensionThe American Journal of Cardiology, 1987
- Beta-Blockers Versus Diuretics in Hypertensive Men: Main Results from the HAPPHY TrialJournal Of Hypertension, 1987
- Antihypertensive Treatment and Serum LipoproteinsJournal Of Hypertension, 1985
- Cardiovascular Risk and Risk Factors in a Randomized Trial of Treatment Based on the Beta-Blocker Oxprenolol: The International Prospective Primary Prevention Study in Hypertension (IPPPSH)Journal Of Hypertension, 1985
- Current problems and future challenges in randomized clinical trials.Circulation, 1984
- The Effect of Spironolactone on Lipid, Glucose and Uric Acid Levels in Blood during Long‐Term Administration to HypertensivesActa Medica Scandinavica, 1983
- Multiple Risk Factor Intervention TrialJAMA, 1982
- Symptom prevalence in hypertensive patientsEuropean Heart Journal, 1982
- Hypertension management: The computer as a participantThe American Journal of Medicine, 1980
- Hypokalaemia and diuretics: an analysis of publications.BMJ, 1980